✦ LIBER ✦

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

✍ Scribed by Julio Rosenstock; Daniel L Lorber; Luigi Gnudi; Campbell P Howard; David W Bilheimer; P-C Chang; Richard E Petrucci; Anders H Boss; Peter C Richardson

Book ID: 117306622
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 256 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)60632-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin lispro low mixture twice daily v

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial

✍ Tinahones, F. J.; Gross, J. L.; Onaca, A.; Cleall, S.; Rodríguez, A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

Once-daily basal insulin glargine versus

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

✍ Reinhard G Bretzel; Ulrike Nuber; Wolfgang Landgraf; David R Owens; Clare Bradle 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 172 KB

Randomized, 1-year comparison of three w

Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections

✍ Riddle, M. C.; Rosenstock, J.; Vlajnic, A.; Gao, L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

Comparison of Basal Insulin Added to Ora

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

✍ Janka, H. U.; Plewe, G.; Riddle, M. C.; Kliebe-Frisch, C.; Schweitzer, M. A.; Yk 📂 Article 📅 2005 🏛 American Diabetes Association 🌐 English ⚖ 126 KB

Insulin glargine versus sitagliptin in i

Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial

✍ Pablo Aschner; Juliana Chan; David R Owens; Sylvie Picard; Edward Wang; Marie-Pa 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 277 KB

Insulin degludec, an ultra-longacting ba

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

✍ Alan J Garber; Allen B King; Stefano Del Prato; Seamus Sreenan; Mustafa K Balci; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 284 KB